| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 1987 | A case-control study on multifactorial etiology of blackfoot disease: A preliminary report | Chen, CJ; Lee, SS; Cheng, SH; Wu, HY; Wang, JD | Blackfoot Disease Research Report 26:1-20 | | | |
| 1987 | Analysis of cancer mortality rates of 789 blackfoot disease patients | Chen, CJ; Cheng, SH; Lee, SS; Wu, HY | Blackfoot Disease Research Report 26:21-37 | | | |
| 2008 | Evidence for improved control of hypertension in Taiwan: 1993-2002. | Su, TC; Bai, CH; Chang, HY; You, SL; Chien, KL; Chen, MF; Chen, HJ; Pan, WH; Tseng, CH; Cheng, SH; Hurng, BS; Hwang, LC; Chen, CJ | Journal of hypertension 26(3), 600-606 | | | |
| 1996 | Hall-effect studies of bulk (R(0.8)Pr(0.2))Ba2Cu3O7-gamma systems (R=Yb, Er, Dy, Gd, Eu and Nd) | Chen, JC; Xu, YH; Cheng, SH; Tung, LC; Wu, MK; Guan, WY | CHINESE JOURNAL OF PHYSICS34(2),243-251 Part 2 | | | |
| 2023 | Longitudinal neutralizing antibody responses after SARS-CoV-2 infection: A convalescent cohort study in Taiwan | Huang, YF; Hsu, FC; Wu, JJ; Lin, YL ; Liu, MT; Yang, CH; Kuo, HS; Chen, YJ; Cheng, CY; Lin, HH; Liao, CC ; Chang, CS; Liang, JJ; Cheng, WY; Huang, JC; Chen, CP; Cheng, SH; Lin, YC; Yang, SH; Chou, YJ | Journal of microbiology, immunology, and infection 56(3), 506-515 | | | |
| 2021 | Safety and immunogenicity of CpG 1018 and aluminium hydroxide-adjuvanted SARS-CoV-2 S-2P protein vaccine MVC-COV1901: interim results of a large-scale, double-blind, randomised, placebo-controlled phase 2 trial in Taiwan | Hsieh, SM; Liu, MC; Chen, YH; Lee, WS; Hwang, SJ; Cheng, SH; Ko, WC; Hwang, KP; Wang, NC; Lee, YL; Lin, YL ; Shih, SR; Huang, CG; Liao, CC ; Liang, JJ; Chang, CS; Chen, C; Lien, CE; Tai, IC; Lin, TY | The Lancet. Respiratory medicine 9(12), 1396-1406 | | | |
| 2020 | Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient | Zhou, D; Duyvesteyn, HME; Chen, CP; Huang, CG; Chen, TH; Shih, SR; Lin, YC; Cheng, CY; Cheng, SH; Huang, YC; Lin, TY; Ma, C ; Huo, J; Carrique, L; Malinauskas, T; Ruza, RR; Shah, PNM; Tan, TK; Rijal, P; Donat, RF; Godwin, K; Buttigieg, KR; Tree, JA; Radecke, J; Paterson, NG; Supasa, P; Mongkolsapaya, J; Screaton, GR; Carroll, MW; Gilbert-Jaramillo, J; Knight, ML; James, W; Owens, RJ; Naismith, JH; Townsend, AR; Fry, EE; Zhao, Y; Ren, J; Stuart, DI; Huang, KYA | Nature Structural & Molecular Biology 27, 950-958 | | | |
| 2024 | The presence of broadly neutralizing anti-SARS-CoV-2 RBD antibodies elicited by primary series and booster dose of COVID-19 vaccine | Chen, X; Mohapatra, A; Nguyen, HTV; Schimanski, L; Kit, Tan T; Rijal, P; Chen, CP; Cheng, SH; Lee, WH; Chou, YC ; Townsend, AR; Ma, C ; Huang, KA | PLoS pathogens 20(6), e1012246 | | | |
